Is it the Right Time to Introduce the Hepatitis B Booster Vaccine in National Immunization Schedule? An Analysis from the Available Evidence

Hepatitis B virus (HBV) infection is a global health concern, and it is considered one of the deadliest infections in the world, having nearly 1.2 million deaths annually. Around 75% of all global HBV carriers live in the Asia-Pacific region. In this regard, India has a prevalence ranging between 2%...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhattacharya, Sudip, Gökdemir, Özden, Bashar, Md Abu, Thiyagarajan, Arulmani, Singh, Amarjeet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
View Point
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117886/
https://www.ncbi.nlm.nih.gov/pubmed/34035566
http://dx.doi.org/10.4103/ijcm.IJCM_439_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117886/
https://www.ncbi.nlm.nih.gov/pubmed/34035566
http://dx.doi.org/10.4103/ijcm.IJCM_439_19

Ejemplares similares